Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Biological Factors > Blood Coagulation Factors > Plasminogen Activators > Streptokinase > Anistreplase
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Blood Coagulation Factors > Plasminogen Activators > Streptokinase > Anistreplase
... > Enzymes and Coenzymes > Enzymes > Hydrolases > Peptide Hydrolases > Endopeptidases > Serine Endopeptidases > Plasminogen Activators > Streptokinase > Anistreplase
... > Enzymes and Coenzymes > Enzymes > Hydrolases > Peptide Hydrolases > Serine Proteases > Serine Endopeptidases > Plasminogen Activators > Streptokinase > Anistreplase

Preferred term

Anistreplase  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Anisoylated Plasminogen-Streptokinase Activator Complex
  • APSAC

Scope note

  • An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.

History note

  • 91

In other languages

URI

http://www.yso.fi/onto/mesh/D016255

Download this concept:

RDF/XML TURTLE JSON-LD Created 5/7/90, last modified 7/1/16